Home/Filings/4/0001437749-19-019541
4//SEC Filing

Nuhaily Dean 4

Accession 0001437749-19-019541

CIK 0001411879other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 8:46 PM ET

Size

5.5 KB

Accession

0001437749-19-019541

Insider Transaction Report

Form 4
Period: 2019-10-01
Nuhaily Dean
Director
Transactions
  • Award

    Restricted Stock Units

    2019-10-01$2.10/sh+2,858$6,00212,585 total
    From: 2019-10-01Exp: 2029-10-01Common Stock (2,858 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock.
  • [F2]The Reporting Person was granted a Restricted Stock Unit on October 1, 2019 of 2,858 shares, which were fully vested on the date of the grant. The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the third quarter of 2019 and was valued on September 30, 2019 in accordance with the approved compensation plan for the non-employee members of the Board of Directors.
  • [F3]These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan.

Issuer

INNOVUS PHARMACEUTICALS, INC.

CIK 0001411879

Entity typeother

Related Parties

1
  • filerCIK 0001751751

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 8:46 PM ET
Size
5.5 KB